Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03079687
Title Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Recruitment Approved for marketing
Gender
Phase Expanded access
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups:
Covered Countries USA


No variant requirements are available.